Neuroprotective Implant Demonstrates Long-Term Vision Preservation in Macular Telangiectasia
A new study demonstrates that the ENCELTO implant, which releases a protective protein in the eye, can slow vision loss in patients with macular telangiectasia type 2, potentially leading to FDA approval and offering a long-term treatment option for this degenerative retinal disease.